Moclobemide is known as a reversible inhibitor of monoamine oxidase A. Some studies support that monoamine oxidase inhibitors can suppress TSH levels in a fairly high percentage of depression patients (Cabanillas et al., 1994; Kadono et al., 1995). The gene discussed is MAOA; the disease is major depressive disorder.